Twenty-gene-based prognostic model predicts lung adenocarcinoma survival

References

• WuXDongLZhangRYingKShenHTransgelin overexpression in lung adenocarcinoma is associated with tumor progressionInt J Mol Med20143458559124938684
   PubMed Web of Science ®Google Scholar
• WoodsLMColemanMPLawrenceGRashbassJBerrinoFRachetBEvidence against the proposition that “UK cancer survival statistics are misleading”: simulation study with National Cancer Registry dataBMJ2011342d339921659366
   PubMed Web of Science ®Google Scholar
• NanavatyPAlvarezMSAlbertsWMLung cancer screening: advantages, controversies, and applicationsCancer Control20142191424357736
   PubMed Web of Science ®Google Scholar
• ShaoLZhangBHeCEfficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapyChin Med J (Engl)201412726627124438614
   PubMed Web of Science ®Google Scholar
• TravisWDPathology of lung cancerClin Chest Med20113266969222054879
   PubMed Web of Science ®Google Scholar
• FieldJKRajiOYThe potential for using risk models in future lung cancer screening trialsF1000 Med Rep20102 pii:38
   Google Scholar
• GantiAKMulshineJLLung cancer screening: panacea or pipe dream?Ann Oncol200516Suppl 2ii215ii21915958460
   PubMed Web of Science ®Google Scholar
• TravisWDBrambillaENoguchiMInternational Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summaryProc Am Thorac Soc2011838138521926387
   PubMedGoogle Scholar
• JemalASiegelRWardECancer statistics, 2008CA Cancer J Clin200858719618287387
   PubMed Web of Science ®Google Scholar
• CuiYLiuJYinHBLiuYFLiuJHFibulin-1 functions as a prognostic factor in lung adenocarcinomaJpn J Clin Oncol20154585485926185140
   PubMed Web of Science ®Google Scholar
• ZhanJWangPNiuMHigh expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinomaHistopathology20156695596525324169
   PubMed Web of Science ®Google Scholar
• XuPZhaoMLiuZElevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patientsInt J Clin Exp Pathol20158158871589426884860
   PubMed Web of Science ®Google Scholar
• MalatiTTumour markers: an overviewIndian J Clin Biochem200722173123105677
   PubMed Web of Science ®Google Scholar
• LeeEMoonAIdentification of biomarkers for breast cancer using databasesJ Cancer Prev20162123524228053957
   PubMedGoogle Scholar
• LoveMIHuberWAndersSModerated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biol20141555025516281
   PubMed Web of Science ®Google Scholar
• ShermanBTHuang daWTanQDAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysisBMC Bioinformatics2007842617980028
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin201161699021296855
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkComprehensive molecular profiling of lung adenocarcinomaNature201451154355025079552
   PubMed Web of Science ®Google Scholar
• GiatromanolakiAKalamidaDSivridisEIncreased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancerLung Cancer2015909810526264650
   PubMed Web of Science ®Google Scholar
• XuPLiuLWangJGenetic variation in BCL2 3′-UTR was associated with lung cancer risk and prognosis in male Chinese populationPLoS One20138e7219723977251
   PubMed Web of Science ®Google Scholar
• LimSMKimEYKimHRGenomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negativeOncotarget201672417226992220
   PubMed Web of Science ®Google Scholar
• FinnRSDeringJConklinDPD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroBreast Cancer Res200911R7719874578
   PubMed Web of Science ®Google Scholar
• LoganJEMostofizadehNDesaiAJPD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivityAnticancer Res2013332997300423898052
   PubMed Web of Science ®Google Scholar
• TaniguchiASugaRMatsumotoKExpression and transcriptional regulation of the human alpha1, 3-fucosyltransferase 4 (FUT4) gene in myeloid and colon adenocarcinoma cell linesBiochem Biophys Res Commun200027337037610873613
   PubMed Web of Science ®Google Scholar
• YanXLinYLiuSAzizFYanQFucosyltransferase IV (FUT4) as an effective biomarker for the diagnosis of breast cancerBiomed Pharmacother20157029930425776515
   PubMed Web of Science ®Google Scholar
• TianLShenDLiXGinsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4Oncotarget20167161926636541
   PubMed Web of Science ®Google Scholar
• Kageyama-YaharaNRiezmanHTransmembrane topology of ceramide synthase in yeastBiochem J200639858559316756512
   PubMed Web of Science ®Google Scholar
• MojakgomoRMbitaZDlaminiZLinking the ceramide synthases (CerSs) 4 and 5 with apoptosis, endometrial and colon cancersExp Mol Pathol20159858559225779024
   PubMed Web of Science ®Google Scholar
• WegnerMSWangerRAOertelSCeramide synthases CerS4 and CerS5 are upregulated by 17beta-estradiol and GPER1 via AP-1 in human breast cancer cellsBiochem Pharmacol20149257758925451689
   PubMed Web of Science ®Google Scholar
• BulunSESimpsonERAromatase expression in women’s cancersAdv Exp Med Biol200863011213218637488
   PubMed Web of Science ®Google Scholar
• CarrubaGAromatase in nontumoral and malignant human liver tissues and cellsAnn N Y Acad Sci2009115518719319250204
   PubMed Web of Science ®Google Scholar
• TuzunerMBOzturkTEronatAPEvaluation of local CYP17A1 and CYP19A1 expression levels as prognostic factors in postmenopausal invasive ductal breast cancer casesBiochem Genet20165478480227365044
   PubMed Web of Science ®Google Scholar
• BondJRobertsEMochidaGHASPM is a major determinant of cerebral cortical sizeNat Genet20023231632012355089
   PubMed Web of Science ®Google Scholar
• LinSYPanHWLiuSHASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinomaClin Cancer Res2008144814482018676753
   PubMed Web of Science ®Google Scholar
• HuZHuangGSadanandamAThe expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancerBreast Cancer Res201012R1820211017
   PubMed Web of Science ®Google Scholar
• KatoTSatoNHayamaSActivation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cellsCancer Res2007678544855317823411
   PubMed Web of Science ®Google Scholar
• Montes de OcaRGurard-LevinZABergerFThe histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinomaMol Oncol2015965767425497280
   PubMed Web of Science ®Google Scholar
• ChoiJSongNHanSThe associations between immunity-related genes and breast cancer prognosis in Korean womenPLoS One20149e10359325075970
   PubMed Web of Science ®Google Scholar
• D’AlterioCAvalloneATatangeloFA prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patientsInt J Cancer201413537939024375277
   PubMed Web of Science ®Google Scholar